Skip to search formSkip to main contentSkip to account menu

Zaroxolyn

Known as: UCB Pharma Brand of Metolazone 
National Institutes of Health

Related topics

Related topics

2 relations

Broader (1)

Metolazone
Metolazone Oral Tablet [Zaroxolyn]

Papers overview

Semantic Scholar uses AI to extract papers important to this topic.
Review
2002
Review
2002
▼Levetiracetam - a new drug for epilepsy
▼Levetiracetam* (Keppra - UCB Pharma) is a new anti-epileptic drug, marketed in the UK since 2000. It is licensed for use as… 
2000
2000
THERAPEUTIC CLASSIFICATION Diuretic/Antihypertensive ACTIONS AND CLINICAL PHARMACOLOGY ZAROXOLYN (metolazone) is a diuretic antihypertensive drug for the treatment of edema. ZAROXOLYN is a…
  • 2000
  • Corpus ID: 9587464
1976
1976
Antihypertensive efficacy of metolazone (Zaroxolyn) alone and combined with reserpine in treatment of essential hypertension.
1976
1976
Antihypertensive efficacy of metolazone (Zaroxolyn) alone and combined with reserpine in treatment of essential hypertension.
1974
1974
Antihypertensive effects of metolazone (zaroxolyn).
1974
1974
Metolazone (zaroxolyn): antihypertensive effects
1972
1972
New drugs--No. 12. Metolazone (zaroxolyn).
By clicking accept or continuing to use the site, you agree to the terms outlined in our Privacy Policy (opens in a new tab), Terms of Service (opens in a new tab), and Dataset License (opens in a new tab)